Clinical Trial Update: A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 follow-on study assessed the long-term safety of aripiprazole in adults with chronic schizophrenia; the trial was terminated and results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 3 | Status: TERMINATED | Results posted: 2015-09-21